BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Recruiting now · Phase 2/Phase 3

Conditions studied: Cervical Cancer

In brief

Phase II study: a study to explore the safety and preliminary efficacy of BAT1308 combined with platinum-based chemotherapy ± Bevacizumab Phase III study: a confirmatory study to evaluate the safety and efficacy of BAT1308 combined with platinum-based chemotherapy ± Bevacizumab as first-line therapy for PD-L1-positive (CPS ≥ 1) persistent, recurrent or metastatic cervical cancer

Key facts

Study ID

NCT06123884

Run by

Bio-Thera Solutions

People needed

526

Starts

2023-12-13

Expected to finish

2027-01-01

Last updated by the study team

2025-02-10

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology — Wuhan, Hubei, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.